Corpus Intelligence IC Memo — JOINT TOWNSHIP DISTRICT MEMORIAL HOS 2026-04-26 16:27 UTC
IC Memo — JOINT TOWNSHIP DISTRICT MEMORIAL HOS
Investment Committee Memorandum | OH | 33 beds | Grade C | EBITDA uplift $7.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

JOINT TOWNSHIP DISTRICT MEMORIAL HOS

CCN 360032 | AUGLAIZE, OH | 33 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

JOINT TOWNSHIP DISTRICT MEMORIAL HOS is a 33-bed suburban community hospital in AUGLAIZE, OH with $95.6M in net patient revenue and a 9.3% operating margin. The hospital serves a payer mix of 31.6% Medicare, 1.7% Medicaid, and 66.7% commercial.

Thesis: Turnaround. Our ML models identify $7.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.3% to 16.6% (+736bps).

Net Revenue HCRIS$95.6M
Current EBITDA COMPUTED$8.9M
Operating Margin COMPUTED9.3%
Occupancy HCRIS34.9%
Revenue / Bed COMPUTED$2.9M
Net-to-Gross HCRIS50.2%
Distress Probability ML50.7%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
99
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 9.3% places it above the state median. Among 99 size-comparable peers (16-66 beds), the median margin is -1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-66), prioritizing same-state peers. 99 hospitals in the comp set.

HospitalStateBedsRevenueMargin
JOINT TOWNSHIP DISTRICT MEMORI (Target)OH33$95.6M9.3%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
AVITA ONTARIO HOSPITALOH49$109.2M16.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.0M+210bp18mo
Cost to Collect4.5%2.5%$1.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.2M+122bp9mo
Clean Claim Rate88.0%96.0%$61K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.0M
Cost to Collect
$1.9M
Denial Rate Reduction
$1.9M
A/R Days Reduction
$1.2M
Clean Claim Rate
$61K
Total EBITDA Uplift$7.0M
Current EBITDA$8.9M
+ RCM Uplift+$7.0M
Pro Forma EBITDA$15.9M
Current Margin9.3%
Pro Forma Margin16.6%
WC Released (1x)$3.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$13.6M$128.8M9.45x56.7%
Base (11x exit)10.0x11.0x$13.6M$146.1M10.72x60.7%
Bull Case9.0x11.0x$12.3M$173.7M14.16x69.9%
Bull (12x exit)9.0x12.0x$12.3M$193.1M15.74x73.6%
Bear Case11.0x10.0x$15.0M$89.2M5.95x42.9%
Bear (11x exit)11.0x11.0x$15.0M$103.0M6.87x47.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 34.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 50.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 99 hospitals with 16-66 beds
  • Same-state prioritization (n=100)
  • Comp margins: P25=-11.2% / P50=-1.7% / P75=11.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.